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Abstract
Background: The time course of regional functional recovery following revascularization with regards to the
presence or absence of infarction is poorly known. We studied the effect of the presence of chronic non-
transmural infarction on the time course of recovery of myocardial perfusion and function after elective
revascularization.
Methods: Eighteen patients (mean age 69, range 52-84, 17 men) prospectively underwent cine magnetic
resonance imaging (MRI), delayed contrast enhanced MRI and rest/stress 99m-Tc-tetrofosmin single photon
emission computed tomography (SPECT) before, one and six months after elective coronary artery bypass grafting
(CABG) or percutaneous coronary intervention (PCI).
Results: Dysfunctional myocardial segments (n = 337/864, 39%) were classified according to the presence (n =
164) or absence (n = 173) of infarction. Infarct transmurality in dysfunctional segments was largely non-transmural
(transmurality = 31 ± 22%). Quantitative stress perfusion and wall thickening increased at one month in
dysfunctional segments without infarction (p < 0.001), with no further improvement at six months. Despite
improvements in stress perfusion at one month (p < 0.001), non-transmural infarction displayed a slower and lesser
improvement in wall thickening at one (p < 0.05) and six months (p < 0.001).
Conclusions: Dysfunctional segments without infarction represent repetitively stunned or hibernating myocardium,
and these segments improved both perfusion and function within one month after revascularization with no
improvement thereafter. Although dysfunctional segments with non-transmural infarction improved in perfusion at
one month, functional recovery was mostly seen between one and six months, possibly reflecting a more severe
ischemic burden. These findings may be of value in the clinical assessment of regional functional recovery in the
time period after revascularization.
Background
Revascularization of dysfunctional but viable myocar-
dium in patients with chronic ischemic heart disease
(CIHD) may offer both functional improvement of myo-
cardium and prognostic benefit [1]. The pathophysiology
underlying the development and recovery of hypofunc-
tioning but viable myocardium in CIHD is not comple-
tely understood [2]. Myocardium which is
hypofunctioning but viable at rest may represent either
hibernating or repetitively stunned myocardium [2].
Therefore, for the purposes of this article, we will use
the collective term “dysfunctional but viable myocar-
dium”. Dysfunctional myocardial segments have been
shown to improve function immediately post-operatively
with no further change 8 days after CABG [3]. This
finding indicates that functional recovery begins early.
However, others have shown that continued functional
recovery is present at follow-up between three and 14
months later [4-9]. Thus, previous studies have shown
varying results with regards to the time course of func-
tional recovery following revascularization for dysfunc-
tional segments with or without infarction, and remote
myocardium, respectively.
Delayed contrast enhanced magnetic resonance ima-
ging (DE-MRI) has shown to be valuable for predicting
regional functional improvement after revascularization
[10]. Furthermore, perfusion of dysfunctional but viable
myocardium has been shown to improve soon after
revascularization [11]. However, it is not known if the
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lowing revascularization is the same for dysfunctional
segments with or without the presence of non-trans-
mural infarction as determined by DE-MRI. Therefore,
we sought to quantitatively assess the influence of the
presence of non-transmural myocardial infarction on
the time course for regional recovery of function by
MRI, and perfusion by
99mTc-tetrofosmin single photon
emission computed tomography (SPECT) over a six
month period after revascularization.
Methods
Study population
The study was approved by the ethics committee on
human research at Lund University Hospital. All
patients provided written informed consent. Patients
were prospectively enrolled between December, 2001
and May, 2005. The inclusion criterion was clinical
selection for first time elective revascularization by cor-
onary artery bypass grafting (CABG) or percutaneous
coronary intervention (PCI). Following revascularization,
changes in medication were determined by the caring
physician. Patients were imaged with cardiac MRI and
rest/stress SPECT prior to revascularization and one
and six months after revascularization. A schematic dia-
gram of the timeline of the study is presented in Figure
1. Exclusion criteria were valvular surgery in adjunct to
revascularization, acute coronary syndrome during the
course of the study, New York Heart Association func-
tional class IV, absence of sinus rhythm, claustrophobia
or contraindications for MRI.
MR Imaging
Left ventricular function and viability were imaged in
the short-axis plane during breath hold using a 1.5T sys-
tem (Magnetom Vision, Siemens, Erlangen, Germany or
I n t e r aC V ,P h i l i p s ,B e s t ,t h e Netherlands). Global and
regional function was imaged using an ECG-triggered
cine gradient echo sequence (Siemens, resolution 1.6 ×
1.6 × 8 mm, gap 2 mm, temporal resolution 50 ms) or a
retrospectively vector-ECG-triggered cine steady-state
free precession sequence (Philips, spatial resolution 1.25
× 1.25 × 8 mm, gap 0 mm, temporal resolution 33 ms,
SENSE factor 2). Infarct imaging was undertaken using
a segmented inversion recovery turbo fast low-angle
shot sequence [12] in either 2D or 3D (2D: Siemens,
acquisition every other heart beat, resolution 1.6 × 1.6 ×
8 mm, gap 2 mm, 3D: Philips, acquisition every heart
beat, 1.6 × 1.6 × 8 mm, gap 0 mm, inversion time set to
null normal myocardium). Imaging was performed 15-
20 minutes after intravenous injection of 0.2 mmol/kg
body weight of an extracellular contrast agent (Magne-
vist®, gadopentetate dimeglumine, Gd-DTPA, Schering
Nordiska AB, Järfälla, Sweden). This approach has been
shown to enhance non-viable myocardium [13] due to
an increased tissue distribution volume of Gd-DTPA in
non-viable regions [14].
SPECT Imaging
Rest and stress SPECT imaging were performed on
separate days, 30 minutes after intravenous injection of
a body weight adjusted dose (500-700 MBq) of
99mTc-
tetrofosmin (Amersham Health, Buckinghamshire, UK).
The same dose was used for rest and stress. For stress
imaging, 5 mg/ml adenosin (Adenosin Item®, Item
Development AB, Stocksund, Sweden) was infused at a
rate of 140 μg/kg/min for 3 minutes before tracer injec-
tion, and continued for 2 minutes following injection.
For those instances where a subject mistakenly had con-
sumed caffeine in the 24 hours prior to stress imaging,
exercise stress was performed using a bicycle ergometer
with a minimum required increase of 85% of the maxi-
mum predicted heart rate. For both rest and stress ima-
ging, the subject was imaged in the supine position with
a dual head camera (ADAC Vertex, Milpitas, California,
USA) using standard methods [15].
Image Analysis
All studies were quantitatively analyzed using a 48-seg-
ment model with 4 midventricular short-axis slices and
12 segments per slice. All images were analyzed using
software developed in-house, including the freely avail-
able software Segment version 1.661 http://segment.hei-
berg.se [16], as described previously in detail [17]. In
summary, the endocardial and epicardial borders of
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Figure 1 Timeline of events in the study. Patients were imaged with both MRI and rest/stress SPECT before revascularization, and after both
one and six months.
Ugander et al. BMC Cardiovascular Disorders 2010, 10:4
http://www.biomedcentral.com/1471-2261/10/4
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end diastole and end systole for determination of wall
thickening. The endocardial and epicardial borders, and
the border of the hyperenhanced region of infarction in
DE-MRI were manually delineated for determination of
infarct transmurality. Infarct transmurality was defined
as the transmural extent of infarction divided by the
total transmural wall thickness. Semi-automatic quantifi-
cation of wall thickening from MRI, infarction from DE-
MRI, and both rest and stress perfusion from SPECT
was performed along radial profiles from the centroid of
the left ventricular lumen at every other degree, yielding
180 measurements per short axis slice. For any given
parameter, measurements were averaged over 30 degrees
to obtain values for the 12-segment per slice model. The
four slices analyzed for all subjects were either 3.0, 4.0,
5.0 and 6.0 cm from the apex (Siemens) or 3.2, 4.0, 4.8
and 5.6 cm (Philips) from the apex, respectively. Slices
closest to the base and apex were excluded to minimize
errors in assessment of wall thickness introduced by the
partial volume effect and atrioventricular plane move-
ment, respectively. Dysfunction was defined as segments
with wall thickening less than 30% [18]. For MR images,
the apex was defined at the time of imaging by com-
mencing the short axis imaging with an apical slice that
encompassed the apical tip of the heart. For SPECT, the
apex was defined manually in a vertical long axis image,
after which contiguous short axis slices were recon-
structed. Slice thickness for reconstructed images were
10 mm or 8 mm for patients imaged by MR using Sie-
mens or Philips scanners, respectively. See Figure 2.
Statistics
Time course data are presented as mean ± SEM. The
number of days between imaging and revascularization
are presented as median and interquartile range (IQR),
d e f i n e da st h er a n g eb e t w e e nt h e2 5
th and 75
th quartile
of the data. All other data are presented as mean ± SD
unless stated otherwise. Variations between data were
tested by paired t-test and independent t-test as appro-
priate. P < 0.05 was considered statistically significant.
Power analysis was calculated retrospectively to deter-
mine the difference in wall thickening which one could
detect with a power of 0.90 using p < 0.05 (two-tailed),
a measurement variability (SD) of 1 mm, and given the
number of myocardial segments involved in the
comparison.
Results
Patient characteristics including times of imaging in
relation to revascularization and baseline medications
are described in Table 1. LVEF was unchanged one
month and at six months following revascularization (44
± 12%, p = 0.253 and 47 ± 13%, p = 0.225). Upon dis-
charge following revascularization, all patients’
medications were unchanged or dosages had been
reduced except for the following. One patient had an
increase in the dosage of both beta-blockers and diure-
tics. Five separate patients had either an increase in
beta-blockers, angiotensin converting enzyme inhibitors
or diuretics, respectively. No patient experienced perio-
perative infarction or died during the study. Two
patients were included but lost to follow-up, and there-
fore not included in the analysis.
Delayed enhancement imaging prior to CABG
DE-MRI was possible in all patients resulting in 864 seg-
ments for analysis. Myocardial segments that were dys-
functional before revascularization (n = 337, 39%) were
classified according to the presence (n = 164) or absence
(n = 173) of infarction. Figure 3 shows the distribution
of infarct transmuralities for segments that were dys-
functional and segments that were not dysfunctional
prior to revascularization. Among dysfunctional seg-
ments with infarction, infarct transmurality was 31 ±
22%, range 1-87%.
Time course of regional function
Retrospective power analysis showed that given a com-
parison of 164 myocardial segments, there was a power
of 0.90 for detecting a change in wall thickening of 0.25
mm. Figure 4A shows the time course of regional wall
thickening for segments that were dysfunctional before
surgery. Non-infarcted segments increased in function
at one month (p < 0.001) with no change thereafter (p =
0.104). Segments with infarction, however, showed
improvement in function at one month (p = 0.013), but
also improvement in function between one and six
months (p < 0.001). Figure 4B shows that segments with
no baseline dysfunction showed a decrease in wall thick-
ening at one month regardless of presence of infarction
(p < 0.001). Among these segments, only those without
infarction showed a significant increase in function
between one and six months (p < 0.001).
Time course of regional perfusion
Stress Perfusion
Figure 4C shows the time course of quantitative stress
perfusion for segments that were dysfunctional before
surgery. Segments with and without infarction differed
from each other in stress perfusion at all time points (p
< 0.001). Both groups showed a similar time course of
improvement at one month (p < 0.001) and no further
improvement at six months (p = 0.366 and p = 0.965).
Figure 4D shows that in segments with no baseline dys-
function both with and without infarction, stress perfu-
sion increased mostly at one month (p < 0.001 and p =
0.002), but also a six months (p = 0.042 and p < 0.001).
Rest Perfusion
Figure 4E shows the time course of rest perfusion for
segments that were dysfunctional before surgery. Both
groups differed in rest perfusion from each other at all
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improved in resting perfusion between baseline and one
month (p = 0.010) and six months (p = 0.002). Figure
4F shows that in segments with no baseline dysfunction
and without infarction, rest perfusion increased at both
one month (p = 0.023) and six months (p < 0.001),
while segments with infarction remained unchanged at
both time points (p = 0.539 and p = 0.348).
Perfusion difference
Figure 4G shows the time course of the quantitative differ-
ence between rest and stress perfusion for segments that
were dysfunctional before surgery. The groups only dif-
fered significantly from each other at baseline (p = 0.035).
Both segments with and without infarction decreased
significantly between baseline and one month (p = 0.008
and p < 0.001) with only non-infarcted segments showing
a change between one and six months (p = 0.025). Figure
4H shows that among segments with no baseline dysfunc-
tion, only those with infarction were relieved of their per-
fusion difference at one month (p = 0.001).
Discussion
To our knowledge, this is the first study to have serially
and quantitatively examined the time course after revas-
cularization of regional recovery of perfusion and func-
tion according to presence of infarction by DE-MRI.
The major findings can be summarized as follows. Dys-
functional segments without infarction gained the
Figure 2 Methods for quantitative assessment of function, infarction and perfusion. (A) A long axis magnetic resonance image (MRI) was
used to plan short axis images of the left ventricle (LV) (parallel white lines). Slices 3-6 were used for analysis. Endocardial and epicardial borders
of the LV were manually delineated on short axis cine MR images in end diastole (ED) and end systole (ES). Wall thickness was quantified in a
12-segment model. Delayed enhancement images (Contrast) were obtained at the same slice positions. Transmurality of infarction was
quantified using manual delineation of the borders of the LV endocardium, epicardium and infarction, employing the same 12-segment model.
(B) Single photon emission computed tomography (SPECT) images were reconstructed in the same fashion as for MRI. Regional perfusion at rest
and stress were assessed quantitatively using the same 12-segment model. See text for details.
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within one month after revascularization. In contrast,
segments with infarction, which was predominantly
<50% transmural, showed a slower functional recovery
which was obvious first at six months, despite improve-
ments in perfusion already at one month.
Time course of recovery of regional function
Several studies have examined functional recovery at
single time points following revascularization based on
the extent of infarction assessed by DE-MRI [10,19,20].
Studies using echocardiography and scintigraphic tech-
niques have demonstrated that the time course of
regional functional recovery following CABG begins
immediately following revascularization and may con-
tinue up to between three and 14 months after surgery
[3-9]. For example, one study showed no functional
improvement in segments with either non-transmural
or transmural infarction as determined by
18F-2-deoxy-
glucose (FDG) uptake using SPECT [8]. Yet, segments
with reduced perfusion but no sign of infarction using
FDG improved function both three and 14 months
after revascularization. The discrepancy in the time
course of functional recovery between previous results
and ours may be due to the limited spatial resolution
Table 1 Patient characteristics
Mean age, y 69 (range 53-84)
Male, n (%) 17 (94)
Caucasian race, n (%) 18 (100)
1-vessel disease, n (%) 3 (17)
2-vessel disease, n (%) 8 (44)
3-vessel disease, n (%) 7 (39)
Diabetes, n (%) 7 (39)
Baseline LVEF*, % 47 ± 11
Baseline medication with...
Beta-blocker, n (%) 15 (83)
Angiotensin converting enzyme inhibitor, n (%) 10 (56)
Diuretic, n (%) 5 (28)
Baseline MR, median days from revascularization -4 (IQR -7 to -2)
Baseline rest SPECT, median days from revascularization -4 (IQR -7 to -4)
Baseline stress SPECT, median days from revascularization -1 (IQR -6 to -1)
One month MR, median days from revascularization 35 (IQR 29 to 42)
One month SPECT, median days from revascularization 31 (IQR 28 to 38)
One month SPECT, median days from revascularization 33 (IQR 29 to 41)
Six month MR, median days from revascularization 196 (IQR 187 to 207)
Six month SPECT, median days from revascularization 196 (IQR 187 to 207)
Six month SPECT, median days from revascularization 197 (IQR 188 to 208)
* denotes that LVEF data was not available for one patient due to insufficient number of MR images. IQR = interquartile range.
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Figure 3 The distribution of infarct transmuralities in the population. Data are presented according the presence (left) or absence (right) of
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Figure 4 Function and perfusion after revascularization for segments according to presence of dysfunction before revascularization.
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99mTc-tetrofosmin single photon emission computed tomography (SPECT). Reversible perfusion is presented as the difference
between rest and stress perfusion (G, H). Black squares and open circles denote myocardial segments without and with infarction, respectively,
as assessed by delayed enhancement MRI. Error bars represent SEM.
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of infarction in previous studies, while we used DE-
MRI. Similar to our findings, it was recently shown
that the time course of regional functional recovery
following revascularization increased with the amount
of regional infarction as determined by DE-MRI [21].
However, that study did not assess perfusion, as in the
current study.
Late improvements in function assessed visually by
echocardiography have been associated with pre-opera-
tive histological and scintigraphic measures of ischemic
burden, defined as a prolonged duration, greater extent
or greater severity of ischemia [4-9]. Such histological
measures of ischemic burden have been shown to
independently correlate to both scintigraphic findings
[22] and an increased duration of ischemia resulting in
a delayed functional recovery [23]. Therefore, one
potential explanation for our findings of the difference
in time course of functional recovery between seg-
ments with and without infarction may be a more
severe degree of ischemic burden in the viable portion
of the segments with infarction. This is supported by
our finding of a greater initial perfusion difference in
these segments. Alternatively, changes in afterload or
compensatory hypertrophy of viable myocardium fol-
lowing revascularization may have contributed to
improved regional function, but this was not studied.
Surprisingly, segments without baseline dysfunction
showed a reduction in wall thickening at one month
regardless of presence of infarction. The reason for
this pattern of remodelling is not known. Although we
found changes in regional function in different regions
within the left ventricle, we found no change in net
global function (ejection fraction) following revascular-
ization in our population. Similar to our findings, stent
revascularization of chronic total coronary occlusion
has been shown to increase wall thickening in dysfunc-
tional segments, but decrease wall thickening in
remote segments, with no net change in ejection frac-
tion [24]. Also, ventriculography has been used to
report improved regional wall motion in hypokinetic
segments but also simultaneous deterioration in wall
motion in initially normokinetic segments [25]. Our
findings of simultaneous improvement and deteriora-
tion of regional function in segments of different base-
line functional status seems reasonable considering the
lack of change in LVEF in our population. Thus, the
improved outcome in revascularized patients [1],
despite sometimes limited improvements in ejection
fraction, may be caused not only by a relief of ischemia
in ischemic but viable regions but also a relief of com-
pensatory hyperfunction in remote and normally func-
tioning myocardium.
Time course of recovery of regional perfusion
Rest Perfusion
T h ec u r r e n ts t u d ya g r e e sw i t hp r e v i o u sf i n d i n g st h a t
scintigraphically assessed regional perfusion at rest
improves soon after surgical and percutaneous revascu-
larization [11].
Stress Perfusion
T h ec u r r e n ts t u d ya l s oa g r e e sw i t hp r e v i o u sf i n d i n g s
showing an improvement in scintigraphically assessed
stress perfusion at single examinations after revasculari-
zation. This has been shown soon after percutaneous
revascularization [26] and both 2-5 weeks [4] and 3-4
months [27] after surgical revascularization. Manyari et
al [28], showed a progressive improvement in stress per-
fusion at 9 days and 3 months, but not 6 months follow-
ing percutaneous revascularization. Taken together with
our findings, it appears that incremental improvement
in perfusion can be identified no later than 3 months
after revascularization.
Perfusion difference
The difference between rest and stress perfusion may
represent stress induced ischemia. Previous studies have
examined the extent of reversible perfusion defects that
exceed a certain severity cut-off value [29]. To our
knowledge, this is the first study to examine the severity
of reversibility of perfusion for given segments in this
manner. Our results for both perfusion and function are
consistent with the proposed mechanism that a greater
ischemic burden may be involved in the delayed func-
tional recovery of segments with infarction.
Infarct transmurality and baseline function
When comparing the distribution of infarct transmural-
ity in relation to baseline dysfunction, the current study
showed, as expected, that there was a greater prevalence
of infarction among segments with baseline dysfunction.
The distribution of infarction in the population was lar-
gely non-transmural. However, it is noteworthy that
there existed segments without baseline dysfunction
which had as much as 100% infarct transmurality. This
may seem counterintuitive. However, this represents
very few myocardial segments (n = 2), and can be
explained by tethering to adjacent segments. For exam-
ple, it has been shown that myocardial segmental func-
tion is influenced moreso by the function of
neighbouring segments than by infarct transmurality as
such [30].
Limitations of the Study
The number of patients is limited, however, power ana-
lysis showed that the study was adequately powered to
assess differences in regional function. The number of
segments with different degrees of transmurality did not
permit an adequate separate analysis for infarction of
different transmuralities. Although care was taken to
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and time points, misalignment due to fundamental dif-
ferences in the imaging modalities is also a potential
limitation.
Conclusions
This study has demonstrated that dysfunctional seg-
ments without infarction, also known as hibernating or
repetitively stunned myocardium, improved in both per-
fusion and function within one month after revasculari-
zation. Although segments with predominantly non-
transmural infarction improved in rest and stress perfu-
sion at one month, functional recovery was slower and
clearly seen first at six months. Despite lack of change
in ejection fraction, remote myocardium showed a
decreased wall thickening suggesting relief of compensa-
tory contractile work. This may be of value in the clini-
cal assessment of regional function and suggests that
evaluation of the coronary revascularization procedure
with regards to regional function should be performed
first 6 months or later after the intervention in patients
with previous infarction. Further studies are warranted
to elucidate the pathophysiological mechanism behind
these findings.
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